SCA Pharmaceuticals: Drug Recall
Recall #D-0555-2023 · 04/10/2023
Class III: Low Risk
Recall Details
- Recall Number
- D-0555-2023
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- SCA Pharmaceuticals
- Status
- Terminated
- Date Initiated
- 04/10/2023
- Location
- Windsor, CT, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 73,312 containers
Reason for Recall
Subpotent Drug: Out of specification results for low potency was obtained.
Product Description
Oxytocin 30 units added to 0.9% Sodium Chloride 500 mL, Rx Only, Single Dose Container, SCA Pharmaceuticals, Windsor, CT 06095, NDC# 70004-085-44
Distribution Pattern
Nationwide in the USA
Other Recalls by SCA Pharmaceuticals
- Class II: Risk 07/20/2023
- Class III: Low Risk 02/24/2023
- Class II: Risk 04/25/2022
- Class II: Risk 04/25/2022
- Class II: Risk 04/25/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.